Browse by author
Lookup NU author(s): Carein Todd,
Professor Ian McKeith,
Professor John O'Brien,
Emeritus Professor Elaine Perry
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Cholinesterase inhibitors (ChEls) are effective symptomatic treatments in dementia with Lewy bodies (DLB), although effects on pathologic mechanisms are unknown. In the first human autopsy study examining the impact of ChEl treatment on brain pathology, we compared treated patients with DLB with matched untreated patients for cortical beta-amyloid (A beta) and tau pathologies. Treated patients with DLB had significantly less parenchymal A beta deposition, which is relevant to disease management and treatment of dementia patients using ChEl.
Author(s): Ballard CG, Chalmers KA, Todd C, McKeith IG, O'Brien JT, Wilcock G, Love S, Perry EK
Publication type: Article
Publication status: Published
ISSN (print): 0028-3878
ISSN (electronic): 1526-632X
Publisher: Lippincott Williams & Wilkins
Altmetrics provided by Altmetric